These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
315 related items for PubMed ID: 32402161
21. Phase 2a study assessing colonization efficiency, safety, and acceptability of Lactobacillus crispatus CTV-05 in women with bacterial vaginosis. Hemmerling A, Harrison W, Schroeder A, Park J, Korn A, Shiboski S, Foster-Rosales A, Cohen CR. Sex Transm Dis; 2010 Dec; 37(12):745-50. PubMed ID: 20644497 [Abstract] [Full Text] [Related]
22. Comparison of oral and vaginal metronidazole for treatment of bacterial vaginosis in pregnancy: impact on fastidious bacteria. Mitchell CM, Hitti JE, Agnew KJ, Fredricks DN. BMC Infect Dis; 2009 Jun 10; 9():89. PubMed ID: 19515236 [Abstract] [Full Text] [Related]
23. Treatment considerations for bacterial vaginosis and the risk of recurrence. Chen JY, Tian H, Beigi RH. J Womens Health (Larchmt); 2009 Dec 10; 18(12):1997-2004. PubMed ID: 20044862 [Abstract] [Full Text] [Related]
24. Efficacy of intravaginal 0.75% metronidazole gel for the treatment of bacterial vaginosis. Hillier SL, Lipinski C, Briselden AM, Eschenbach DA. Obstet Gynecol; 1993 Jun 10; 81(6):963-7. PubMed ID: 8497364 [Abstract] [Full Text] [Related]
25. A blinded, randomized controlled trial of high-dose vitamin D supplementation to reduce recurrence of bacterial vaginosis. Turner AN, Carr Reese P, Fields KS, Anderson J, Ervin M, Davis JA, Fichorova RN, Roberts MW, Klebanoff MA, Jackson RD. Am J Obstet Gynecol; 2014 Nov 10; 211(5):479.e1-479.e13. PubMed ID: 24949544 [Abstract] [Full Text] [Related]
26. Relationship of specific vaginal bacteria and bacterial vaginosis treatment failure in women who have sex with women. Marrazzo JM, Thomas KK, Fiedler TL, Ringwood K, Fredricks DN. Ann Intern Med; 2008 Jul 01; 149(1):20-8. PubMed ID: 18591634 [Abstract] [Full Text] [Related]
27. Treatment of male partners and recurrence of bacterial vaginosis: a randomised trial. Colli E, Landoni M, Parazzini F. Genitourin Med; 1997 Aug 01; 73(4):267-70. PubMed ID: 9389947 [Abstract] [Full Text] [Related]
28. Comparing the effect of sucrose gel and metronidazole gel in treatment of clinical symptoms of bacterial vaginosis: a randomized controlled trial. Khazaeian S, Navidian A, Navabi-Rigi SD, Araban M, Mojab F, Khazaeian S. Trials; 2018 Oct 26; 19(1):585. PubMed ID: 30367673 [Abstract] [Full Text] [Related]
29. Restoring vaginal microbiota: biological control of bacterial vaginosis. A prospective case-control study using Lactobacillus rhamnosus BMX 54 as adjuvant treatment against bacterial vaginosis. Recine N, Palma E, Domenici L, Giorgini M, Imperiale L, Sassu C, Musella A, Marchetti C, Muzii L, Benedetti Panici P. Arch Gynecol Obstet; 2016 Jan 26; 293(1):101-107. PubMed ID: 26142892 [Abstract] [Full Text] [Related]
32. An exploratory pilot study evaluating the supplementation of standard antibiotic therapy with probiotic lactobacilli in south African women with bacterial vaginosis. Marcotte H, Larsson PG, Andersen KK, Zuo F, Mikkelsen LS, Brandsborg E, Gray G, Laher F, Otwombe K. BMC Infect Dis; 2019 Sep 18; 19(1):824. PubMed ID: 31533663 [Abstract] [Full Text] [Related]
33. The effect of prebiotic vaginal gel with adjuvant oral metronidazole tablets on treatment and recurrence of bacterial vaginosis: a triple-blind randomized controlled study. Hakimi S, Farhan F, Farshbaf-Khalili A, Dehghan P, Javadzadeh Y, Abbasalizadeh S, Khalvati B. Arch Gynecol Obstet; 2018 Jan 18; 297(1):109-116. PubMed ID: 28983665 [Abstract] [Full Text] [Related]
35. Recurrent bacterial vaginosis following metronidazole treatment is associated with microbiota richness at diagnosis. Gustin AT, Thurman AR, Chandra N, Schifanella L, Alcaide M, Fichorova R, Doncel GF, Gale M, Klatt NR. Am J Obstet Gynecol; 2022 Feb 18; 226(2):225.e1-225.e15. PubMed ID: 34560047 [Abstract] [Full Text] [Related]
36. Prevention of recurrence of bacterial vaginosis using lactobacilli-containing vaginal tablets among women with HIV: a randomized, placebo-controlled, double-blinded phase IV trial. Bangar S, Sonar P, Mane A, Sane S, Kadam A, Katendra TL, Rahane G, Sinha A, Sahay S. Int J Infect Dis; 2023 Apr 18; 129():197-204. PubMed ID: 36773716 [Abstract] [Full Text] [Related]